Key Market Indicators
The country ranked number 15 in 2021, Egypt overtook at $34,097,000. France, Italy and Spain respectively came in numbers 2, 3 and 4 in this ranking. Portuguese diabetes medicine sales are set to reach nearly $600 million by 2026, up from $503 million in 2021. This represents a growth rate of 2.9% year-on-year, with an average 10.2% rise since 2005. Portugal ranks eighth in terms of market size, with Greece ahead at $503 million. Canada, Spain and Italy come in second, third and fourth respectively. Portuguese insulin exports will reach $2.5 million by 2026, up from $2.4 million in 2021. This is an average year-on-year growth rate of 1.2%, with a 3.1% increase since 1993. Portugal ranks thirtieth in terms of exports, with Barbados ahead at $2.4 million. France, Italy and China come in second, third and fourth respectively. Portuguese insulin imports are set to reach $36 million by 2026, up from $34 million in 2021. This is an average year-on-year growth rate of 1.2%, with a 4.5% rise since 1993. Portugal ranks fifteenth in terms of imports, with Egypt ahead at $34 million. France, Italy and Spain come in second, third and fourth respectively.
